Global DHA and EPA Products Market Size, Share and Trends Analysis Report, By Type (Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA)), By Source (Fish Oil, Algae Oil, and Krill Oil), By Application (Infant Formulae, Dietary Supplements and Pharmaceuticals) Forecast (2022-2028)

The global DHA and EPA products market is anticipated to grow at a significant CAGR of 5.9% during the forecast period (2022-2028). Long-chain omega-3 polyunsaturated fatty acids (O-3s) EPA and DHA are prevalent in fish, shellfish, algae, and genetically altered plants. In order to develop and function efficiently, the body requires EPA and DHA omega-3s at all stages of life. EPA and DHA are gaining popularity around the globe and are increasingly becoming a part of people’s everyday diets. The rising prevalence of chronic diseases and people pursuing preventative healthcare measures are the main factors for this rising demand. Furthermore, increasing applications of EPA and DHA in food, dietary supplements, and clinical nutrition had also increased significantly in past few years.

On the basis of type, the DHA segment hold the major share in the market as it is a vital building block for the growth and maturation of an infant’s brain and retina, the DHA segment is primarily driven by increased demand and its inclusion into infant formulas and nutritional goods aimed at children’s health. Fish and algae oils are the most common sources of this nutrient. It’s also widely utilized in fortified foods and dietary supplements to treat type 2 diabetes, coronary artery disease (CAD), dementia, and attention deficit hyperactivity disorder (ADHD). DHA has been successfully used in geriatric nutrition products due to its healthy aging-related effects. Additionally, the industry is benefiting from an increasing number of product releases around the globe. For instance, in April 2020, DSM has introduced two new high-quality lipid powders for newborn nutrition called DHASCO-B and ARASCO powders, each of which contains at least 110 mg/g DHA or ARA (arachidonic acid). These powders comprise vegetarian DHA omega-3 and ARA omega-6 sources that are safe and acceptable for use in newborn and follow-on formulae, as well as growing-up milk products.

The market for EPA and DHA products in North America is primarily driven by product and technology advancements. Leading companies are investing in technological developments in order to generate better omega constituents for a broader range of uses. In May 2020, DSM has added a new plant-based high-potency DHA oil to its maternal and new-born nutrition range. With a minimum of 550 mg/g natural triglyceride DHA, this component has a higher potency, allowing producers to reach equal DHA dosages in smaller product formats and meet the latest maternal nutrition trend for convenient capsule and tablet sizes. Additionally, the region is dominated by the tendency of supplement intake rather than functional food consumption. Consumers select high-concentration dietary supplements to suit their DHA/EPA nutritional needs. As a result, the region’s ingredient sector is growing.

The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2021, KD Pharma introduced Alga3, a sustainable, vegan omega-3 solution. The advanced technology and production flexibility of KD Nutra enable the production of a wide range of omega-3 concentrates. Similarly, In June 2021, Polaris introduced Omegavie DHA 800 Sensory Qualitysilver 5 algae, a high-concentration microalgae DHA component derived from microalgae (Schizochytrium sp.) that are high in vitamins, proteins, pigments, and enzymes. The component provided polyunsaturated fatty acids from a plant-based, long-term source (PUFAs).

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Source
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- DSM, KD Pharma Group SA, ADM, Corbion, and Novastep, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global DHA and EPA Products Market Report by Segment

By Type

• EPA
• DHA

By Source

• Fish Oil
• Algae Oil
• Krill Oil

By Application

• Infant Formulae
• Dietary Supplements
• Pharmaceuticals

Global DHA and EPA Products Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa